| mSin3A is a key scaffolding protein of the Sin3 transcriptional corepressor complex that regulates gene silencing and chromatin organization through recruitment of histone deacetylases (HDACs) despite lacking intrinsic DNA-binding activity. mSin3A contains multiple paired amphipathic helix (PAH) domains that mediate interactions with diverse transcriptional repressors such as REST, Mad-Max, and p53, while simultaneously associating with HDAC1/2, RbAp48, SAP proteins, and other chromatin regulators to assemble a stable multiprotein repression complex. Through these interactions, mSin3A bridges sequence-specific transcription factors to HDAC activity at promoters of genes involved in cell cycle regulation, differentiation, apoptosis, and development, leading to histone H3 and H4 deacetylation, chromatin compaction, and transcriptional repression. In Notch signaling, mSin3A cooperates with CSL-associated repressors to maintain low basal expression of target genes such as Hes1 until pathway activation displaces the repressor complex, whereas during p53-mediated stress responses, mSin3A enhances repression of survival genes, including Bcl2, by promoting local chromatin condensation at p53-bound promoters. mSin3A plays essential roles in cortical neurogenesis by suppressing premature neuronal differentiation programs in neural progenitor cells, thereby coordinating the transition between proliferation and maturation, while loss of mSin3A in embryonic fibroblasts results in derepression of E2F target genes, cell cycle abnormalities, and resistance to apoptosis. Conserved PAH domains together with the C-terminal region provide multiple protein interaction surfaces necessary for assembly and regulation of Sin3 complexes. Dysregulation of mSin3A contributes to human disease, as SIN3A haploinsufficiency is associated with Witteveen-Kolk syndrome characterized by neurodevelopmental delay and intellectual disability, whereas reduced mSin3A expression in breast cancer has been linked to increased tumor invasion and progression. |
